Session I: Background and Rationale for LAA Closure 第一场:左心耳封堵的背景和理论依据 |
|||
Moderator 主持人 | Changsheng Ma 马长生, Saibal Kar | ||
Discussant 讨论者 | Dongming Hou, Matthew J. Price | ||
1:30 PM- |
Techniques, Results, and Lessons from Surgical LAA Closure 外科左心耳封堵的技术、结果及经验 |
Zhe Zheng 郑哲 | |
1:40 PM- |
Who Is the Right Candidate for LAA Closure: Warfarin Eligible and Warfarin Ineligible, or both? 哪些人适合做左心耳封堵?是适合吃华法林的,华法林禁忌的,还是两者都可 |
Matthew J. Price | |
1:50 PM- |
LAAC Health Economics Value 左心耳封堵的卫生经济学分析 |
Dongming Hou | |
2:00 PM- |
Status of Anticoagulation Therapy of AF Patients in China and Patient Selections for LAA Closure 中国房颤患者抗凝现状与左心耳封堵的病人选择 |
Weijian Huang 黄伟剑 | |
2:10 PM- |
Creating of a Successful Multidisciplinary Team Based on LAA Closure 从左心耳封堵看以疾病为中心的跨学科合作 |
Jian-an Wang 王建安 | |
2:20 PM- |
Old and New Anticoagulants for Stroke Prevention: Benefits and Risks 预防卒中的传统和新型的抗凝药物:获益和风险 |
Xinchun Yang 杨新春 | |
2:30 PM- |
Panel Discussion with Audience Q&A 专家讨论及听众问答 |
||
Session II: Evidence-Based Medicine of LAA Closure 第二场:左心耳封堵的循证医学 |
|||
Moderator 主持人 | Dejia Huang 黄德嘉, Cheuk-Man Yu | ||
Discussant 讨论者 | Steven R. Bailey, Ted E. Feldman, Simon Cheung-Chi Lam, Zulu Wang 王祖禄 | ||
2:35 PM- |
Update of Clinical Results with the Watchman Device Watchman封堵器的临床研究结果更新 |
Ted E. Feldman | |
2:45 PM- |
Update of Clinical Results with the Amplatzer Cardiac Plug (ACP) ACP封堵器的临床研究结果更新 |
David Hildick-Smith | |
2:55 PM- |
Real World Usage of LAA Closure for Prevention of Stroke 真实世界左心耳封堵预防脑卒中的情况 |
Saibal Kar | |
3:05 PM- |
LAA Closure in China: Quality Control and Standardized Treatment 左心耳封堵中国质量控制与规范化治疗进展 |
He Huang 黄鹤 | |
3:15 PM- |
The Liftech LAmbre Occluder: Device, Techniques, and Clinical Data 先健LAmbre封堵器:器械、技术及临床数据 |
Yat-Yin Lam | |
3:25 PM- |
A New LAAC Device: Experimental and Clinical Studies 新型左心耳封堵器的实验和临床研究 |
Yongwen Qin 秦永文 | |
Debate: Is LAA Closure Preferred First-line Treatment in AF Patients after Stent Implantation? 辩论:刚刚做过支架植入术的房颤患者左心耳封堵是否应该作为一线治疗? |
|||
3:35 PM- |
No: A Combination of Antiplatelet Agents and Warfarin/NOACs Should Be Tried First! 不,联合抗血小板和抗凝药物应该作为首选 |
Muhammad Munawar | |
3:45 PM- |
Yes: Minimize the Bleeding Risk and Improve the Long-term Outcomes! 是的,应该将出血风险降至最低、改善长期预后 |
Steven R. Bailey | |
3:55 PM- |
Panel Discussion with Audience Q&A 专家讨论及听众问答 |
||
Session III: How to Close the LAA 第三场:怎样封堵左心耳 |
|||
Moderator 主持人 | Saibal Kar, Yawei Xu 徐亚伟, Ben He 何奔 | ||
Discussant 讨论者 | Maurice Buchbinder, Xingpeng Liu 刘兴鹏, Matthew J. Price, Xi Su 苏晞, Xianxian Zhao 赵仙先 | ||
4:00 PM- |
Optimal Technique for LAA Closure: Step by Step 左心耳封堵的优化技术:逐步讲解 |
Maurice Buchbinder | |
4:10 PM- |
Tips and Tricks for LAA Closure 左心耳封堵操作关键要领与技巧 |
Matthew J. Price | |
4:20 PM- |
Ablation + LAA Closure Are the One-Stop Solution for AF Patients 射频+封堵是房颤患者的一站式治疗方案 |
Huimin Chu 储慧民 | |
4:30 PM- |
Challenging Case Reviews 挑战性病例回顾 |
Xi Su 苏晞 | |
4:40 PM- |
A Single Center Experience with More Than 150 LAA Closure Cases in China 中国左心耳封堵单中心150例一线临床应用经验 |
Zhiyuan Song 宋治远 | |
4:50 PM- |
Prevention and Management of Complications during and after LAA Closure 左心耳封堵术中和术后并发症的预防与管理 |
Horst Sievert | |
5:00 PM- |
Adjourn 休会 |